Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA

Citations Over TimeTop 25% of 2016 papers

Abstract

BH3 mimetic compounds induce tumor cell death through targeted inhibition of anti-apoptotic BCL2 proteins. Resistance to one such compound, ABT-737, is due to increased levels of anti-apoptotic MCL1. Using chemical and genetic approaches, we show that resistance to ABT-737 is abrogated by inhibition of the mitochondrial RING E3 ligase, MARCH5. Mechanistically, this is due to increased expression of pro-apoptotic BCL2 family member, NOXA, and is associated with MARCH5 regulation of MCL1 ubiquitylation and stability in a NOXA-dependent manner. MARCH5 expression contributed to an 8-gene signature that correlates with sensitivity to the preclinical BH3 mimetic, navitoclax. Furthermore, we observed a synthetic lethal interaction between MCL1 and MARCH5 in MCL1-dependent breast cancer cells. Our data uncover a novel level at which the BCL2 family is regulated; furthermore, they suggest targeting MARCH5-dependent signaling will be an effective strategy for treatment of BH3 mimetic-resistant tumors, even in the presence of high MCL1.

Related Papers

• → Ubiquitination and Degradation of Mutant p53(2007)223 cited
• → The Ubiquitin E3 Ligase MaLUL2 Is Involved in High Temperature-Induced Green Ripening in Banana Fruit(2020)22 cited
• → Promiscuous Interactions of gp78 E3 Ligase CUE Domain with Polyubiquitin Chains(2012)33 cited
• → The poxvirus encoded ubiquitin ligase, p28, is regulated by proteasomal degradation and autoubiquitination(2014)11 cited
• → The Antibiotic Treatment Index: A Novel Tool to Improve Antibiotic Resistance Monitoring(2014)